Prenatal diagnosis of homozygous α°-thalassaemia by direct DNA analysis of chorionic villi in Singapore

1989 ◽  
Vol 25 (3) ◽  
pp. 161-163
Author(s):  
J. A. M. A. TAN ◽  
H. B. WONG ◽  
A. KITZIS ◽  
E. H. YAP ◽  
C. ANANDAKUMAR ◽  
...  
2019 ◽  
Vol 33 (7-8) ◽  
pp. 191-9
Author(s):  
Sunarto Sunarto

Thalassemia is an individual as well as a community health problem in some countries. It causes a lifelong suffering for the affected individuals. There is no treatment other than supportive, i.e. regular transfusions and removal of iron overload from the body. Only by such continuous and expensive treatment thalassemic patients can-generally achieve nearly normal health, but the health burden of such therapy for a large number of thalassemic patients is unaffordable by the affected communities. Prevention of the births of thalassemic babies is the choice for controlling the thalassemia and has been successful in many countries. For this purpose reliable and time accurate prenatal diagnosis is a conditio sine qua non. Blood fetal sampling is safe and can be done after 16 weeks gestation, amniocentesis after 14 weeks, and even chorionic villi sampling as early as 8 weeks gestation. In vitro globin synthesis analysis applied to the fetal blood sample is very reliable to measure the rate of synthesis of the globin chains that make up the hemoglobin. The-DNA analysis of the fibroblasts obtained by amniocentesis or of the chorionic villus sample is very sensitive and specific for the diagnosis of the genetic disorder in thalassemias. By involving the prenatal diagnosis, the birth of B-homozygous thalassemia has decreased by up to 90%.


2011 ◽  
Vol 31 (11) ◽  
pp. 1111-1112 ◽  
Author(s):  
Jérôme Toutain ◽  
Gwendoline Soler ◽  
Jacques Horovitz ◽  
Robert Saura

1996 ◽  
Vol 16 (4) ◽  
pp. 345-348 ◽  
Author(s):  
M. L. KWEE ◽  
J. R. LO TEN FOE ◽  
F. ARWERT ◽  
G. PALS ◽  
K. MADAN ◽  
...  

The Lancet ◽  
1984 ◽  
Vol 324 (8401) ◽  
pp. 521-522 ◽  
Author(s):  
C.M. Vimal ◽  
A.H. Fensom ◽  
D. Heaton ◽  
R.H.T. Ward ◽  
P. Garrod ◽  
...  

Blood ◽  
1988 ◽  
Vol 71 (4) ◽  
pp. 983-988 ◽  
Author(s):  
M Pirastu ◽  
G Saglio ◽  
C Camaschella ◽  
A Loi ◽  
A Serra ◽  
...  

Abstract In this study, we defined by haplotype characterization combined with oligonucleotide hybridization or direct restriction endonuclease analysis the specific beta-thalassemia mutations in a representative sample of beta-thalassemia chromosomes from patients with homozygous beta-thalassemia originating from different parts of Italy. We characterized the mutations in 90% of the thalassemia chromosomes and found that three mutations, namely the beta+IVS 1–110, beta degrees -39 and beta+IVS 1–6 are prevalent in the Italian population. Most of the patients investigated were compound heterozygotes for two beta- thalassemia mutations, and only a few were homozygotes for one mutant. On the basis of these findings, we predict that prenatal diagnosis in this population would be feasible in most cases by fetal DNA analysis with the oligonucleotide method using a limited number of oligonucleotide probes selected after screening parents for the most common beta-thalassemia mutations. We have also devised a method based on hybridization with a mixture of two oligonucleotides that allows rapid and simultaneous screening of prospective parents for the two most frequent mutations in Italians, the beta+IVS 1–110 and beta degrees -39 mutants. This method may be applicable to prenatal diagnosis in cases at risk for the genetic compound of these mutations.


1988 ◽  
Vol 11 (2) ◽  
pp. 123-130 ◽  
Author(s):  
L. Poenaru ◽  
L. Castelnau ◽  
A-M. Besançon ◽  
H. Nicolesco ◽  
S. Akli ◽  
...  

Author(s):  
Tracy B. Perry ◽  
Michel J. J. Vekemans ◽  
Abby Lippman ◽  
Emily F. Hamilton ◽  
Paul J. R. Fournier

Sign in / Sign up

Export Citation Format

Share Document